Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This statistic shows the price changes in surgical and drug treatments for cardiovascular disease in the U.S. from 2005 to 2015. A percutaneous coronary angioplasty surgical procedure increased in cost from 47,692 U.S. dollars in 2005 to 95,251 dollars in 2015.
Price changes for U.S. surgical and drug treatments for cardiovascular disease between 2005 and 2015 (in U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Premium Statistic Soft tissue fillers facial rejuvenation market size worldwide from 2016-2026
- Premium Statistic Chemical peel facial rejuvenation market size worldwide from 2016-2026
- Basic Statistic IBD patients in the U.S. who received select treatments as of 2017
- Basic Statistic U.S. adults who would rate selected pharma features as excellent or good 2017
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Premium Statistic Naloxone use for suspected drug overdose in EMS events in the U.S. from 2012-2016
- Premium Statistic U.S. adults impression of the U.S. pharma companies fairness towards patients
- Premium Statistic U.S. adults impression of the U.S. pharma companies amount of research
- Basic Statistic U.S. adults impression of the U.S. pharma companies quality of research
About the region
10
- Basic Statistic Rx medicine exclusion from U.S. pharmacy formularies by company 2014-2022
- Premium Statistic Projected decline in hepatitis C complications in the U.S. by 2050
- Basic Statistic Prescription medicines: U.S. spending growth 2000-2022
- Basic Statistic Decline in patients with chronic conditions by quality of life U.S. 2002-2012
- Basic Statistic Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Premium Statistic U.S. prescription market: market share of pharmacy benefit managers 2022
- Premium Statistic Atenolol out-of-pocket price in the U.S. 2004-2021
- Basic Statistic Metoprolol out of pocket cost U.S. 2004-2021
- Basic Statistic Select prescription drug price percent changes in the US 2010-2017
- Premium Statistic Prescription drug price development in the U.S. by select drug 2010-2017
Other regions
10
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Basic Statistic Number of users of heart disease medication in Sweden 2023, by age and gender
- Premium Statistic Diagnostics and personalized medicine projects in Spain 2023, by therapeutic area
- Basic Statistic Total public drug program spending in Canada by therapy 2022
- Basic Statistic Usage of infliximab biosimilars in select countries 2018
- Premium Statistic Largest domestic pharma companies in Brazil 2015
- Basic Statistic Express Scripts' revenue 2006-2017
- Premium Statistic Self-medication market sales in Europe in 2020, by country
- Basic Statistic Value of pharmaceutical sales in Switzerland 2002-2022
Related statistics
10
- Basic Statistic Leading U.S. states by unpaid care given by Alzheimer/dementia caregivers 2023
- Basic Statistic Leading U.S. states by value of unpaid care given by dementia caregivers 2023
- Basic Statistic Alzheimer and other dementia caregivers' unpaid care in the U.S. 2011-2023
- Premium Statistic Reasons for hospitalizations of US Alzheimer sufferers 2010
- Basic Statistic Ages of Alzheimer/dementia caregivers in the U.S. in 2023
- Basic Statistic Stress reported by Alzheimer and other dementia caregivers in the US 2014
- Basic Statistic Leading U.S. states by number of Alzheimer/dementia caregivers 2023
- Basic Statistic Percentage of U.S. nursing home residents with cognitive impairment in 2008-2009
- Basic Statistic Hospital drug spending in Canada by province 2018
- Basic Statistic Share of drug spending in hospitals in Canada by province 2018
Further related statistics
9
- U.S. insulin market distribution: leading companies 2011
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Merck & Co total assets 2009-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Expenditure worldwide on diabetes by market 2013-2018
- Global pharmaceutical pipeline by therapy area 2013-2017
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
Further Content: You might find this interesting as well
Statistics
- U.S. insulin market distribution: leading companies 2011
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Merck & Co total assets 2009-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Expenditure worldwide on diabetes by market 2013-2018
- Global pharmaceutical pipeline by therapy area 2013-2017
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
PhRMA. (July 24, 2018). Price changes for U.S. surgical and drug treatments for cardiovascular disease between 2005 and 2015 (in U.S. dollars) [Graph]. In Statista. Retrieved May 16, 2024, from https://www.statista.com/statistics/886406/price-change-for-cardiovascular-disease-treatments-us/
PhRMA. "Price changes for U.S. surgical and drug treatments for cardiovascular disease between 2005 and 2015 (in U.S. dollars)." Chart. July 24, 2018. Statista. Accessed May 16, 2024. https://www.statista.com/statistics/886406/price-change-for-cardiovascular-disease-treatments-us/
PhRMA. (2018). Price changes for U.S. surgical and drug treatments for cardiovascular disease between 2005 and 2015 (in U.S. dollars). Statista. Statista Inc.. Accessed: May 16, 2024. https://www.statista.com/statistics/886406/price-change-for-cardiovascular-disease-treatments-us/
PhRMA. "Price Changes for U.S. Surgical and Drug Treatments for Cardiovascular Disease between 2005 and 2015 (in U.S. Dollars)." Statista, Statista Inc., 24 Jul 2018, https://www.statista.com/statistics/886406/price-change-for-cardiovascular-disease-treatments-us/
PhRMA, Price changes for U.S. surgical and drug treatments for cardiovascular disease between 2005 and 2015 (in U.S. dollars) Statista, https://www.statista.com/statistics/886406/price-change-for-cardiovascular-disease-treatments-us/ (last visited May 16, 2024)
Price changes for U.S. surgical and drug treatments for cardiovascular disease between 2005 and 2015 (in U.S. dollars) [Graph], PhRMA, July 24, 2018. [Online]. Available: https://www.statista.com/statistics/886406/price-change-for-cardiovascular-disease-treatments-us/